Hypotriglyceridemic effects of apple polyphenols extract via up-regulation of lipoprotein lipase in triton WR-1339-induced mice

详细信息    查看全文

• 作者：Nan Yao (1)
  Rong-rong He (2)
  Xiao-hui Zeng (1)
  Xue-jun Huang (1)
  Tie-liang Du (1)
  Jing-chao Cui (1)
  Kurihara Hiroshi (2)
  
• 关键词：apple polyphenols extract ; Triton WR ; 1339 ; triglyceride ; lipoprotein lipase ; peroxisome proliferator ; activated receptor alpha
• 刊名：Chinese Journal of Integrative Medicine
• 出版年：2014
• 出版时间：January 2014
• 年：2014
• 卷：20
• 期：1
• 页码：31-35
• 全文大小：530 KB
• 作者单位：Nan Yao (1)
  Rong-rong He (2)
  Xiao-hui Zeng (1)
  Xue-jun Huang (1)
  Tie-liang Du (1)
  Jing-chao Cui (1)
  Kurihara Hiroshi (2)
  
  1. Guangdong Provincial Institute of Traditional Chinese Medicine, Guangzhou, 510095, China
  2. Institute of Traditional Chinese Medicine and Natural Products, Jinan University, Guangzhou, 510632, China
  
• ISSN：1993-0402

文摘

Objective To investigate the anti-hyperlipidemic effects of apple polyphenols extract (APE) in Triton WR-1339-induced endogenous hyperlipidemic model. Methods Firstly, APE was isolated and purified from the pomace of Red Fuji Apple and contents of individual polyphenols in APE were determined using high-performance liquid chromatography-mass spectrometry (HPLC-MS). Secondly, forty male National Institude of Health (NIH) mice were randomly divided into 5 groups with 8 animals in each group. The Fenofibrate Capsules (FC) group and APE groups received oral administration of respective drugs for 7 consecutive days. All mice except those in the normal group were intravenously injected through tail vein with Triton WR-1339 on the 6th day. Serum and livers from all the mice were obtained 18 h after the injection. The changes in serum total cholesterol (TC), triglyceride (TG), lipoprotein lipase (LPL) and hepatic triglyceride lipase (HTGL) were measured by respective kits. Finally, expression of hepatic peroxisome proliferator-activated receptor alpha (PPARα) mRNA was measured by real-time reverse transcription-polymerase chain reaction (RT-PCR) method. Results Serum TC and TG levels significantly increased in Triton WR-1339-induced model group compared with the normal group (P<0.01). Oral administration of APE [200 and 400 mg/(kg day)] dose-dependently reduced the serum level of TG in hyperlipidemic mice (P<0.01). Serum LPL and HTGL activities significantly decreased in Triton WR-1339-induced model group compared with the normal group (P<0.05). Oral administration of APE [200 and 400 mg/(kg day)] dose-dependently elevated the serum activity of LPL in hyperlipidemic mice (P<0.05 or P<0.01). Furthermore, compared with the normal group, hepatic mRNA level of PPARα in the model group significantly decreased (P<0.01). Oral administration of APE [200 and 400 mg/(kg day)] dose-dependently elevated the expression of PPARα in hyperlipidemic mice (P<0.05 or P<0.01) Conclusion APE could reduce TG level via up-regulation of LPL activity, which provides new evidence to elucidate the anti-hyperlipidemic effects of APE.